Details of the Drug | DrugMAP

General Information of Drug (ID: DMFURZ6)

Drug Name

BI 765128

Indication

Disease Entry	ICD 11	Status	REF
Diabetic retinopathy	9B71.0	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecule

Cross-matching ID

TTD ID: DBF26U

References

1	ClinicalTrials.gov (NCT04919499) A First in Human Trial to Study Safety and Tolerability of Single Rising Intravitreal Doses (oPen Label, Non-randomized, Uncontrolled) and in Addition the Early Biological Response of mulTiple Intravitreal Doses (Double-masked, RandomIzed, Sham-controlleD) of BI 765128 in Panretinal photocoaGulation (PRP) Treated Diabetic rEtinopathy (DR) Patients With Diabetic Macular Ischemia (DMI) - the PARTRIDGE Study. U.S.National Institutes of Health.